Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LSM12 pseudogene 1 (LSM12P1) is a non-protein-coding genetic element classified as a pseudogene. It shares sequence similarity with the LSM12 gene, which encodes an RNA-binding protein implicated in RNA splicing and is upregulated in certain cancers such as lung and oral squamous cell carcinoma[1][2]. However, LSM12P1 itself is not known to produce a functional protein and has no direct biological, therapeutic, or diagnostic role[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LSM12 pseudogene 1 (LSM12P1).